Is Esperion Therapeutics, Inc. (ESPR) a Buy, Sell, or Hold?
Esperion Therapeutics, Inc.
NASDAQ:ESPR
$3.18 USD
$0 (0.0%)
- Volume
- 59.09M
- Average Volume
- 15.45M
- Market Capitalization
- $661.15M
- P/E Ratio
- -131.40
- Dividend Yield
- 99.37%
- Price Target
- $3.16
- Year High
- $4.18
- Year Low
- $1.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.53
Analyst Rating
N/A
0 Rating Score
UPSIDE/DOWNSIDE
0.6% UPSIDE
$3.16 Price Target
UPSIDE/DOWNSIDE HIGH
-3.0% DOWNSIDE
$3.28 Price Target High
UPSIDE/DOWNSIDE LOW
0.6% UPSIDE
$3.16 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Kristen Kluska | $9 | $2.56 | 2025-09-25 02:15 PM | 251.6% |
| Cantor Fitzgerald | Kristen Kluska | $8 | $3.04 | 2024-12-17 06:36 AM | 163.2% |
| Needham | Serge Belanger | $12 | $6.53 | 2022-05-03 08:00 PM | 83.8% |
| Wells Fargo | Derek Archila | $20 | $25.59 | 2021-05-03 08:00 PM | -21.8% |